XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 3,317 $ 16,349
Operating expenses    
Research and development 19,972 25,593
General and administrative 10,691 9,498
Total operating expenses 30,663 35,091
Operating loss (27,346) (18,742)
Other income (expense):    
Loss from equity method investments (952)  
Interest expense (42)  
Interest income 172 53
Total other income (expense), net (822) 53
Net loss and net loss attributable to common stockholders $ (28,168) $ (18,689)
Net loss per share attributable to common stockholders- basic and diluted $ (0.46) $ (0.33)
Weighted average shares of common stock outstanding- basic and diluted 61,031,775 56,625,024